Prognostic value of [18F]FET-PET in diffuse low-grade (grade 2) gliomas after the 2021 classification of CNS tumors
European Journal of Nuclear Medicine and Molecular Imaging · 2026-02 · 53 (3) · 1951-1961
DOI: 10.1007/s00259-025-07543-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 10.09.2025. Verfasst von Michael Müther und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Glioma, Positron-Emission Tomography, Tyrosine, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Münster.
Abstract (Originalsprache)
Purpose
Amino acid PET with [ 18 F]-fluoroethylthyrosine ([ 18 F]FET-PET) is frequently utilized in gliomas. Most studies on prognostication based on amino acid PET comprise mixed cohorts of brain tumors with low- and high-grade features. The objective of this study was to assess the potential prognostic value of [ 18 F]FET-PET-based markers in the group of grade 2 adult-type diffuse gliomas, as defined by the WHO CNS 2021 classification.
Methods
Retrospectively, all therapy-naive patients having undergone [ 18 F]FET-PET before maximal safe resection of grade II / 2 gliomas over a time of 2012—2022 were included. Diagnoses were updated according to the WHO CNS 2021 classification. [ 18 F]FET-PET were quantitatively evaluated, including dynamic PET acquisition if available. The primary outcome measure was progression-free survival (PFS), progression was defined by RANO 2.0 criteria.
Results
In the cohort of WHO grade 2 gliomas, 57 (69%) patients were diagnosed with astrocytoma, IDH-mutant. Twenty-six (31%) patients were diagnosed with oligodendroglioma, IDH-mutant and 1p/19q-codeleted. Quantitative PET uptake parameters (TBR max , TBR mean , BTV) were significantly higher in oligodendroglioma compared to astrocytoma (p < 0.001). In all patients, Cox regression analysis of clinical and imaging parameters did not identify any factor that significantly impacted PFS. In the subgroup of astrocytoma without adjuvant treatment, for patients with TBR max above 1.9 PFS was significantly shorter (p < 0.001).
Conclusion
Preoperative [ 18 F]FET-PET can provide prognostic information in distinct subgroups of diffuse low-grade gliomas not having undergone adjuvant therapies. Following external validation, preoperative [ 18 F]FET-PET may possibly be employed as a decision-support tool to inform the choice of adjuvant therapies in astrocytoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, University Hospital Münster, Münster, Germany.
- West German Cancer Center, Münster, Germany.
- Department of Nuclear Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, 48149, Münster, Germany.
- European Institute for Molecular Imaging, University of Münster, Münster, Germany.
- Department of Neurology, University Hospital Münster, Münster, Germany.
- Department of Radiology, University Hospital Münster, Münster, Germany.
ORCID-Profile: Wolfgang Roll
Förderung
- Universitätsklinikum Münster
Zitieren
APA
Müther, M., König, L., Backhaus, P., Stummer, W., Grauer, O. M., Schäfers, M., Schindler, P., Weckesser, M., & Roll, W. (2026). Prognostic value of [18F]FET-PET in diffuse low-grade (grade 2) gliomas after the 2021 classification of CNS tumors. European Journal of Nuclear Medicine and Molecular Imaging, 53(3), 1951-1961. https://doi.org/10.1007/s00259-025-07543-1
Vancouver
Müther M, König L, Backhaus P, Stummer W, Grauer OM, Schäfers M, et al. Prognostic value of [18F]FET-PET in diffuse low-grade (grade 2) gliomas after the 2021 classification of CNS tumors. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(3):1951-1961. doi:10.1007/s00259-025-07543-1
BibTeX
@article{Mther2026,
author = {Müther, Michael and König, Lorenz and Backhaus, Philipp and Stummer, Walter and Grauer, Oliver M and Schäfers, Michael and Schindler, Philipp and Weckesser, Matthias and Roll, Wolfgang},
title = {Prognostic value of [18F]FET-PET in diffuse low-grade (grade 2) gliomas after the 2021 classification of CNS tumors},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {3},
pages = {1951--1961},
doi = {10.1007/s00259-025-07543-1}
}
EUVIMED